Ulker, M. Et Al. 2015. ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.19, no.3 , 207-213.

Ulker, M., Duman, B. B., ŞAHİN, B., & GÜMÜRDÜLÜ, D., (2015). ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.19, no.3, 207-213.

Ulker, Mehmet Et Al. "ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine," WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.19, no.3, 207-213, 2015

Ulker, Mehmet Et Al. "ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine." WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.19, no.3, pp.207-213, 2015

Ulker, M. Et Al. (2015) . "ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine." WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.19, no.3, pp.207-213.

@article{article, author={Mehmet Ulker Et Al. }, title={ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine}, journal={WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY}, year=2015, pages={207-213} }